Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus

Virology Journal

Volumn 5, Issue , 2008, Pages

  Steurbaut, Stephane ^a   Merckx, Ellen ^a   Rombaut, Bart ^a   Vrijsen, Raf ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; ENVIROXIME; GAMMA INTERFERON; HEMIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; ANTIVIRUS AGENT; CCL5 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL LINE; CYTOLYSIS; DRAW CELL LINE; IMMUNOPATHOGENESIS; MACROPHAGE; MODULATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERSISTENT INFECTION; PROTEIN MICROARRAY; RAW CELL LINE; RECEPTOR UPREGULATION; VIRUS REPLICATION; ANIMAL; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS INFECTION;

MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

ANIMALS; ANTIVIRAL AGENTS; CARDIOVIRUS INFECTIONS; CELL LINE; CELL SURVIVAL; CHEMOKINE CCL5; CYTOKINES; GENE EXPRESSION; MACROPHAGES; MICE; THEILOVIRUS; VIRUS REPLICATION;

EID: 49649093186     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-5-89     Document Type: Article

References (56)

1. Multiple sclerosis. Animal model:Theiler's virus infection in mice. MC Dal Canto HL Lipton, Am J Pathol 1977 88 497 500 195474
2. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. HL Lipton, Infect Immun 1975 11 1147 1155 164412
3. Theiler's virus infection: a model for multiple sclerosis. EL Oleszak JR Chang H Friedman CD Katsetos CD Platsoucas, Clin Microbiol Rev 2004 17 174 207 14726460 10.1128/CMR.17.1.174-207.2004
4. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. HL Lipton G Twaddle ML Jelachich, J Virol 1995 69 2525 2533 7884902
5. Role of macrophages during Theiler's virus infection. CP Rossi M Delcroix I Huitinga A McAllister RN van E Claassen M Brahic, J Virol 1997 71 3336 3340 9060706
6. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. RS Fujinami A Zurbriggen HC Powell, J Neuroimmunol 1988 20 25 32 10.1016/0165-5728(88)90110-5 2460501
7. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. M Yamada A Zurbriggen RS Fujinami, J Exp Med 1990 171 1893 1907 1693653 10.1084/jem.171.6.1893
8. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. RJ Clatch HL Lipton SD Miller, J Immunol 1986 136 920 927 2416841
9. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. SD Miller CL Vanderlugt WS Begolka W Pao RL Yauch KL Neville Y Katz-Levy A Carrizosa BS Kim, Nat Med 1997 3 1133 1136 10.1038/nm1097-1133 9334726
10. The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. P Borrow P Tonks CJ Welsh AA Nash, J Gen Virol 1992 73 ( Pt 7) 1861 1865 10.1099/0022-1317-73-7-1861 1629706
11. Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. I Tsunoda LQ Kuang RS Fujinami, J Virol 2002 76 12834 12844 12438608 10.1128/JVI.76.24.12834- 12844.2002
12. Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. I Tsunoda LQ Kuang M Kobayashi-Warren RS Fujinami, J Virol 2005 79 14640 14646 16282464 10.1128/JVI.79.23.14640-14646. 2005
13. IFN-gamma production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: role of viral strains and capsid proteins. I Tsunoda JE Libbey M Kobayashi-Warren RS Fujinami, J Neuroimmunol 2006 172 85 93 10.1016/j.jneuroim.2005.11.004 16375978
14. Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. LM Hoffman BT Fife WS Begolka SD Miller WJ Karpus, J Neurovirol 1999 5 635 642 10.3109/13550289909021292 10602404
15. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. JK Olson AM Girvin SD Miller, J Virol 2001 75 9780 9789 11559811 10.1128/JVI.75.20.9780-9789.2001
16. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease. JP Palma D Kwon NA Clipstone BS Kim, J Virol 2003 77 6322 6331 12743289 10.1128/JVI.77.11.6322- 6331.2003
17. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. JP Palma BS Kim, J Neuroimmunol 2004 149 121 129 10.1016/j.jneuroim.2003.12.025 15020072
18. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. M Chamorro C Aubert M Brahic, J Virol 1986 57 992 997 3951022
19. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. HL Lipton AS Kumar M Trottier, Virus Res 2005 111 214 223 10.1016/j.virusres.2005.04.010 15893838
20. Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence. S Steurbaut B Rombaut R Vrijsen, J Neurovirol 2006 12 108 115 10.1080/13550280600714120 16798672
21. The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. PA Benton DJ Barrett RL Matts RE Lloyd, J Virol 1996 70 5525 5532 8764065
22. Hemin inhibits the interferon-beta-induced antiviral state in established cell lines. G Fiorucci ZA Percario EM Coccia A Battistini GB Rossi G Romeo E Affabris, J Interferon Cytokine Res 1995 15 395 402 7544231
23. Derepression of ferritin messenger RNA translation by hemin in vitro. JJ Lin S niels-McQueen MM Patino L Gaffield WE Walden RE Thach, Science 1990 247 74 77 10.1126/science.2294594 2294594
24. Heme oxygenase 1, nuclear factor E2-related factor 2, and nuclear factor kappaB are involved in hemin inhibition of type 2 cationic amino acid transporter expression and L-Arginine transport in stimulated macrophages. PS Tsai CC Chen PS Tsai LC Yang WY Huang CJ Huang, Anesthesiology 2006 105 1201 1210 10.1097/00000542-200612000-00020 17122583
25. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. BA Heinz LM Vance, J Virol 1995 69 4189 4197 7769678
26. Postabsorption neutralization of poliovirus. R Vrijsen A Mosser A Boeye, J Virol 1993 67 3126 3133 8388493
27. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. S Goodbourn L Didcock RE Randall, J Gen Virol 2000 81 2341 2364 10993923
28. Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence. S Steurbaut B Rombaut R Vrijsen, J Neurovirol 2007 13 47 55 10.1080/13550280601145357 17454448
29. Immunology of hepatitis C virus infection. L Huang MJ Koziel, Curr Opin Gastroenterol 2000 16 558 564 10.1097/00001574-200011000-00017 17031138
30. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. Y Persidsky HE Gendelman, J Leukoc Biol 2003 74 691 701 10.1189/jlb.0503205 14595004
31. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. M Brahic JF Bureau T Michiels, Annu Rev Microbiol 2005 59 279 298 10.1146/annurev.micro.59.030804.121242 16153171
32. Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound. B Verheyden K Andries B Rombaut, Antiviral Res 2004 61 189 194 10.1016/j.antiviral.2003.10.004 15168800
33. Poliovirus 2C region functions during encapsidation of viral RNA. LM Vance N Moscufo M Chow BA Heinz, J Virol 1997 71 8759 8765 9343235
34. Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus. A Munoz RA Garcia A Perez-Aranda, Antimicrob Agents Chemother 1986 30 192 195 2428301
35. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. Y Hiraoka C Kishimoto H Takada M Nakamura M Kurokawa H Ochiai K Shiraki, J Am Coll Cardiol 1996 28 1610 1615 10.1016/S0735-1097(96)00372-5 8917278
36. Nitric oxide inhibits viral replication in murine myocarditis. CJ Lowenstein SL Hill A Lafond-Walker J Wu G Allen M Landavere NR Rose A Herskowitz, J Clin Invest 1996 97 1837 1843 8621766 10.1172/JCI118613
37. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. K Andries B Dewindt J Snoeks R Willebrords EK van R Stokbroekx PA Janssen, Antimicrob Agents Chemother 1992 36 100 107 1317142
38. The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B. J Zoll WJ Melchers JM Galama FJ van Kuppeveld, J Virol 2002 76 9664 9672 12208945 10.1128/JVI.76.19.9664-9672.2002
39. Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages. C Martinat I Mena M Brahic, J Virol 2002 76 12823 12833 12438607 10.1128/JVI.76.24.12823-12833.2002
40. Theiler's murine encephalomyelitis virus (TMEV) subgroup strain-specific infection in neural and non-neural cell lines. M Obuchi J Yamamoto N Uddin T Odagiri H Iizuka Y Ohara, Microbiol Immunol 1999 43 885 892 10553681
41. Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state. C Shaw-Jackson T Michiels, J Virol 1997 71 8864 8867 9343249
42. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. L Fiette C Aubert U Muller S Huang M Aguet M Brahic JF Bureau, J Exp Med 1995 181 2069 2076 7759999 10.1084/jem.181.6.2069
43. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. M Rodriguez LJ Zoecklein CL Howe KD Pavelko JD Gamez S Nakane LM Papke, J Virol 2003 77 12252 12265 14581562 10.1128/JVI.77.22.12252-12265.2003
44. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. MK Njenga MJ Coenen N DeCuir HY Yeh M Rodriguez, J Neurosci Res 2000 59 661 670 10.1002/(SICI)1097-4547(20000301)59:5<661::AID-JNR9>3. 0.CO;2-E 10686594
45. Chemokines and central nervous system disorders. WJ Karpus, J Neurovirol 2001 7 493 500 10.1080/135502801753248079 11704881
46. Innate immune response induced by Theiler's murine encephalomyelitis virus infection. BS Kim JP Palma D Kwon AC Fuller, Immunol Res 2005 31 1 12 10.1385/IR:31:1:01 15591618
47. Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. DJ Theil I Tsunoda JE Libbey TJ Derfuss RS Fujinami, J Neuroimmunol 2000 104 22 30 10.1016/S0165-5728(99)00251-9 10683511
48. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. J Hvas C McLean J Justesen G Kannourakis L Steinman JR Oksenberg CC Bernard, Scand J Immunol 1997 46 195 203 10.1046/j.1365-3083.1997.d01-100.x 9584001
49. RANTES: a genetic risk marker for multiple sclerosis. R Gade-Andavolu DE Comings J MacMurray RK Vuthoori WW Tourtellotte RM Nagra LA Cone, Mult Scler 2004 10 536 539 10.1191/1352458504ms1080oa 15471370
50. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. JW Tyner O Uchida N Kajiwara EY Kim AC Patel MP O'Sullivan MJ Walter RA Schwendener DN Cook TM Danoff MJ Holtzman, Nat Med 2005 11 1180 1187 10.1038/nm1303 16208318
51. Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. S Paul T Michiels, J Gen Virol 2006 87 1237 1246 10.1099/vir.0.81642-0 16603526
52. Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease. WJ Karpus KJ Kennedy BT Fife JL Bennett MC Dal Canto SL Kunkel NW Lukacs, J Neurovirol 2006 12 251 261 10.1080/ 13550280600873819 16966216
53. Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinases. L Hause FM Al-Salleeh TM Petro, Antiviral Res 2007 76 159 167 10.1016/j.antiviral.2007.06.013 17675254
54. ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's virus-infected RAW264.7 cells. TM Petro, Immunol Lett 2005 97 47 53 10.1016/j.imlet.2004.09.013 15626475
55. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. S Nitayaphan MM Toth RP Roos, J Virol 1985 53 651 657 2578578
56. Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug. DC Delong SE Reed, J Infect Dis 1980 141 87 91 6245149